Atara Biotherapeutics Operating Expenses 2011-2026 | ATRA

Annual Operating Expenses Atara Biotherapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	361 M	309 M	296 M	237 M	122 M	81.2 M	58.4 M	28.2 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
361 M	28.2 M	187 M

Quarterly Operating Expenses Atara Biotherapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	72.4 M	76.2 M	-	89.1 M	83.7 M	95.5 M	-	90.2 M	87.9 M	81.8 M	-	74.7 M	78 M	74.7 M	-	72.6 M	75.5 M	67.9 M	-	60.2 M	52.6 M	42.5 M	-	31.7 M	27.9 M	26.2 M	-	25.9 M	19.5 M	17.1 M	-	12.3 M	15.1 M	9.31 M	-	5.95 M	4.53 M	7.08 M	-	2.55 M	-	-	4.09 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
95.5 M	2.55 M	47.9 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Precigen PGEN	120 M	$ 3.1	-0.96 %	$ 758 M	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Ascendis Pharma A/S ASND	338 M	$ 220.9	2.49 %	$ 5 B	Danmark
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Amphastar Pharmaceuticals AMPH	216 M	$ 19.57	1.77 %	$ 915 M	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.33	0.76 %	$ 339 M	Britain
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
ProQR Therapeutics N.V. PRQR	59.8 M	$ 1.58	6.04 %	$ 99.5 M	Niderland
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	142 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
Corbus Pharmaceuticals Holdings CRBP	85.3 M	$ 8.31	1.59 %	$ 111 M	USA
CRISPR Therapeutics AG CRSP	668 M	$ 47.09	1.42 %	$ 4.23 B	Schweiz
Arbutus Biopharma Corporation ABUS	52.2 M	$ 4.53	5.1 %	$ 868 M	Canada
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
CytomX Therapeutics CTMX	98.6 M	$ 4.22	-0.47 %	$ 582 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Cyclacel Pharmaceuticals CYCC	12 M	-	-5.98 %	$ 34.1 M	USA